Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Precision Biosciences Inc (NQ: DTIL ) 8.290 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Precision Biosciences Inc < Previous 1 2 3 4 5 6 7 8 9 Next > A Preview Of Precision BioSciences's Earnings August 03, 2023 Via Benzinga Precision BioSciences to Report Second Quarter Results on August 4, 2023 August 01, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences Provides Updates on Azer-Cel FDA Meeting, Potential Partnerships and Timing of In Vivo R&D Day July 27, 2023 From Precision BioSciences, Inc. Via Business Wire 3 Penny Stocks to Catapult You Into the Millionaires’ Club July 13, 2023 These penny stocks can deliver tremendous upside from their depressed range. Wall Street analysts can back it up! Via InvestorPlace Precision BioSciences Announces Oral Presentation of Positive ARCUS® Gene Editing Data at International Liver Congress 2023 June 22, 2023 From Precision BioSciences, Inc. Via Business Wire Preview: Precision BioSciences's Earnings May 08, 2023 Via Benzinga Looking Into Precision BioSciences's Return On Capital Employed March 14, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Wednesday June 14, 2023 On Wednesday, 33 stocks hit new 52-week lows. Via Benzinga Precision BioSciences to Present at Upcoming June Investor Conferences June 05, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences Provides Update on Allogeneic CAR T Programs and Regulatory Path Forward May 31, 2023 From Precision BioSciences, Inc. Via Business Wire Preview: Precision BioSciences's Earnings March 08, 2023 Via Benzinga Precision BioSciences to Provide an Update on its Allogeneic CAR T Programs via Hosted Virtual Webcast and Conference Call on May 31, 2023 May 25, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences to Participate in Upcoming Stifel Genetic Medicines Day May 24, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences Presents Preclinical Data Demonstrating Potential of ARCUS for Treatment of Duchenne Muscular Dystrophy at the American Society of Gene & Cell Therapy 26th Annual Meeting May 19, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences Announces Publication of its Preclinical In Vivo Gene Editing Abstract on Duchenne Muscular Dystrophy Program for the American Society of Gene & Cell Therapy 26th Annual Meeting May 12, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences Reports First Quarter 2023 Financial Results and Provides Business Update May 09, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) May 08, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences to Report First Quarter 2023 Results on May 9, 2023 May 02, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences to Present Preclinical In Vivo Gene Editing Research for its ARCUS HBV Program at Upcoming Global Hepatitis Summit 2023 April 20, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences Announces Late-Breaking Abstract of Preclinical In Vivo Gene Editing Research Selected for Oral Presentation at the American Society of Gene & Cell Therapy 26th Annual Meeting April 19, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences Receives U.S. and International Patent Allowances for Proprietary PCSK9 ARCUS Nuclease April 13, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences to Participate in Upcoming Guggenheim Healthcare Talks Conference March 27, 2023 From Precision BioSciences, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023 March 14, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday March 14, 2023 Tuesday's morning session saw 84 companies set new 52-week lows. Via Benzinga Precision BioSciences Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update March 09, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences to Report Fourth Quarter and Fiscal Year 2022 Results on March 9, 2023 March 02, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences Announces Senior Leadership Promotions and Organizational Changes February 24, 2023 From Precision BioSciences, Inc. Via Business Wire Precision BioSciences to Participate in Upcoming H.C. Wainwright Cell Therapy Virtual Conference February 22, 2023 From Precision BioSciences, Inc. Via Business Wire There's a Lot of Upside For Emerging Gene-Editing Companies February 21, 2023 These four gene-editing companies are brand new, with very high upside potential. The industry itself is still emerging, which means more growth could come. Via MarketBeat Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) February 14, 2023 From Precision BioSciences, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
